Pfizer's cumulative analysis of post-authorization adverse eve | Noticias Corona-virus

Pfizer's cumulative analysis of post-authorization adverse event reports of PF-07302048 (BNT162B2)

https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf

@auraxchan